Sulphonamides Market Research and Forecast 2019-2025

Orion Market Research

Sulphonamides Market Size, Share, Growth, Research and Forecast 2019-2025 Request a free sample of our report on Global https://www.omrglobal.com/request-sample/sulphonamides-market

Sulphonamides

Market:

-----------------------------------------------------------------------------------Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

The global sulphonamides market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Rising prevalence of infectious diseases is primarily driving the demand for sulphonamides as an antimicrobial to inhibit bacterial growth. Sulphonamides are used for the treatment of several infectious diseases including meningitis, tuberculosis, urinary tract infections (UTIs), and eye infections. Rising demand for contact lens has increased the concerns regarding eye infection. As per the American Academy of Ophthalmology, in the US, approximately one million eye infections that require a trip to the doctor or hospital happen annually, several of these infections are related to the use of contact lens.

A full report of Global Sulphonamides Market is available at: https://www.omrglobal.com/industryreports/sulphonamides-market As per the Centers for Disease Control and Prevention (CDC), in the US, nearly 45 million people wear contact lenses. Wearing a contact lens is a major risk factor for microbial keratitis, a corneal infection caused by bacteria. In addition, poor hygiene is a major risk factor for several eye complications, such as microbial keratitis and another contact lens–associated inflammation. This results in the adoption of topical sulphonamides as an anti-infectives for the treatment of infections of the eye. It can be applied as an eye drop or ointment to stop bacterial growth. Doctors generally recommend to not wear contact lens while using this medication.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/requestsample/sulphonamides-market Rising prevalence of urinary tract infections is further encouraging the demand for sulphonamides.

Increasing ageing population is among the major causes of UTIs among individuals. However, it can affect people of all age group. As per the World Health Organization (WHO), urinary tract infection (UTI) is the major cause of morbidity and healthcare spending among all age group individuals. An estimated 40%-50% of women witnessed having UTI at some point in their lives. This increases the demand for antimicrobials for the treatment of UTIs. Sulfonamides act to restrict bacterial dihydropteroate synthase by competing with para-aminobenzoic acid (PABA). It interferes with the uptake of PABA into folic acid, which is an important component for the development of bacteria. Trimethoprim-sulfamethoxazole (TMP-SMX) can be recommended by the doctors to take the benefit of the synergy between trimethoprim and sulfonamides. The activity of TMPSMX comprises common urinary tract pathogens, both aerobic gram-negative and gram-positive bacteria, except Pseudomonas aeruginosa. Therefore, the rising prevalence of infectious diseases has led to the global sulphonamides market.

Global Sulphonamides Market- Segmentation

By Route of Administration  

Oral Topical

By Application      

Urinary Tract Infection Skin Infection Eye Infection Respiratory Tract Infection Gastrointestinal Tract Infection Others

For more customized data, request for report customization @ https://www.omrglobal.com/reportcustomization/sulphonamides-market Global Sulphonamides Market– Segment by Region North America  

United States Canada

Europe      

Germany United Kingdom France Spain Italy Rest of Europe

Rest of the World  

Middle East & Africa Latin America

Asia-Pacific    

China Japan India Rest of Asia-Pacific

Company Profiles             

AA Pharma Inc. Abbott Laboratories Allergan plc Bausch Health Companies Inc. Bayer AG Boehringer Ingelheim International GmbH Cipla Ltd. DK Pharmachem Pvt. Ltd. F. Hoffmann-La Roche AG GlaxoSmithKline plc Lexine Technochem Pvt. Ltd. Mylan N.V. Pfizer Inc.

About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other researchbased services.

For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404